Skip to main content

7AlphaC4 (7 alpha-hydroxy-4-cholesten-3-one)

CPT 82542
Synonyms
  • 7 alpha-hydroxy-4-cholesten-3-one
  • 7AC4
  • 7C4
  • Bile Acid Diarrhea (BAD) marker
  • Bile Acid Malabsorption (BAM) marker
  • Bile Acid precursor or intermediate
  • Bile Acid Synthesis surrogate
  • C4

Test Details

Methodology

Tandem Mass Spectrometry (LC-MS/MS)

Result Turnaround Time

10 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Related Documents

For more information, please view the literature below.

Bile Acid Malabsorption (7alphaC4) white paper

Use

Serum 7AlphaC4 is a surrogate measure of stool bile acids (BA) and elevated levels may be diagnostic for bile acid malabsorption (BAM), also known as bile acid diarrhea (BAD).

Special Instructions

Sample collection in the morning after overnight fast is recommended.

Limitations

Please note that this 7AlphaC4 test is for Bile Acid Malabsorption/Diarrhea. For cholestasis of pregnancy, Bile Acids, Fractionated and Total, LC/MS-MS [503640] is a different test.

Custom Additional Information

7AlphaC4 is a diagnostic blood test for diarrhea due to excess colonic bile acids.

Bile acids (BAs) are detergent molecules necessary to emulsify fat and facilitate interstinal absorption of lipids and fat-soluble vitamins. When BA reabsorption in the ileum is impaired, more BAs in the colon cause loose or watery stool while less BAs re-entering enterohepatic circulation results in increased hepatic BA synthesis (due to less negative feedback inhibition).

7 Alpha-hydroxy-4-cholesten-3-one (7AlphaC4) is an intermediate in the synthesis of BAs from cholesterol. With increased hepatic BA synthesis, 7AlphaC4 concentrations in serum also increase. Elevated serum 7AlphaC4 can be diagnostic of bile acid malabsorption (BAM) or bile acid diarrhea (BAD).

BAM/BAD results from impaired ileal reabsorption (e.g. in Crohn's disease, radiation ileitis, ileal resection), increased BA production (many cases of functional diarrhea and diarrhea-predominant irritable bowel syndrome (IBS-D)), or excess hepatic BA synthesis (in hypertriglyceridemia and in patients on metformin therapy).

BAM/BAD occurs in up to 50% of functional diarrhea and in 33-60% of IBS-D and is co-existent in 35% of microscopic colitis and in 42% of inflammatory bowel disease (IBD) with or without ileal disease.

Specimen Requirements

Specimen

Serum or plasma, frozen

Volume

0.5 mL

Minimum Volume

0.4 mL

Container

Serum from a gel-barrier tube; serum from red-top tube; serum transfer tube; plasma from lavender-top tube; plasma from green-top tube; or plasma transfer tube

Collection Instructions

Serum/plasma must be separated from cells within two hours of venipuncture. Transfer serum/plasma to a plastic transport tube before freezing.

Stability Requirements

Temperature

Period

Room temperature

1 day

Refrigerated

9 days

Frozen

9 days

Freeze/thaw cycles

Stable x6

Storage Instructions

Freeze.

Causes for Rejection

Incorrect sample type

References

Camilleri, Nadeau, A, Tremaine, et al. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil. 2009 Jul;21(7):734-e43.19368662
Camilleri M, Nurko, S. Bile Acid Diarrhea in Adults and Adolescents. Neurogastroenterol Motil. 2022 Apr;34(4):e14287.34751982
Lenicek M, Duricova D, Komarek V, et al. Bile acid malabsorption in inflammatory bowel disease: assessment by serum markers. Inflamm Bowel Dis. 2011 Jun;17(6):1322-1327.21058331
Lyutakov I, Ursini R, Penchev P, et al. Methods for Diagnosing Bile Acid Malabsorption: A Systematic Review. BMC Gastroenterol. 2019 Nov 14;19(1)185.31726982
Schiller LR, Pardi DS, Sellin JH. Chronic Diarrhea: Diagnostic and Management. Clin Gastroenterol Hepatol. 2017 Feb;15(2):182-193.e3.27496381
Vijayvargiya P, Camilleri M. Update on Bile Acid Malabsorption: Finally Ready for Prime Time? Curr Gastroenterol Rep. 2018 Mar 26;20(3):10.29582208
Vijayvargiya P, Camilleri, M, Carlson, P, et al. Performance characteristics of serum C4 and FGF19 measurements to to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea. Alimentary Pharmacol Ther. 2017 Sep;46(6):581-588.28691284
Vijayvargiya P, Camilleri M, Shin A, Saenger A. Diagnostic Methods for Bile Acid malabsorption in Clinical Practice. Clin Gastroenterol Hepatol. 2013 Oct;11(10):1232-1239.23644387

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
520550 7AlphaC4 94866-1 520551 7AlphaC4 ng/mL 94866-1
Order Code520550
Order Code Name7AlphaC4
Order Loinc94866-1
Result Code520551
Result Code Name7AlphaC4
UofMng/mL
Result LOINC94866-1